Analyst Recommendations
RBC Capital analyst issues OUTPERFORM recommendation for SNMRF on May 7, 2024 04:32AM ET. SNMRF was trading at $4.464 at issue of the analyst recommendation.The overall analyst consensus...May 7, 2024
RBC Capital analyst issues SECTOR PERFORM recommendation for ITGGF on May 7, 2024 04:31AM ET. ITGGF was trading at $0 at issue of the analyst recommendation.
Historical Analyst Recommendations
Latest...May 7, 2024 ITGGF -0.25%
BMO Capital analyst issues MARKET PERFORM recommendation for NSRCF on May 7, 2024 04:25AM ET. The previous analyst recommendation was Outperform.NSRCF was trading at $0.46 at issue of...May 7, 2024 NSRCF -5.53%
UBS analyst issues NEUTRAL recommendation for ULS on May 7, 2024 04:40AM ET. ULS was trading at $36.07 at issue of the analyst recommendation.
Historical Analyst Recommendations
Latest 10 recommendations
May 7, 2024 ULS 1.46%
Barclays analyst issues OVERWEIGHT recommendation for OMC on May 7, 2024 04:28AM ET. The previous analyst recommendation was Equal-Weight.OMC was trading at $93.19 at issue of the analyst...May 7, 2024 OMC -2.65%
Wolfe Research analyst issues OUTPERFORM recommendation for PODD on May 7, 2024 04:48AM ET. PODD was trading at $176.4 at issue of the analyst recommendation.The overall analyst consensus...May 7, 2024 PODD -2.57%
Liberum analyst issues BUY recommendation for FRRDF on May 7, 2024 04:58AM ET. FRRDF was trading at $32.5 at issue of the analyst recommendation.The overall analyst consensus :...May 7, 2024 PODD -2.57%
Jefferies analyst issues BUY recommendation for ULS on May 7, 2024 04:43AM ET. ULS was trading at $36.07 at issue of the analyst recommendation.
Historical Analyst Recommendations
Latest 10 recommendations
May 7, 2024 ULS 1.46%
Jefferies analyst issues HOLD recommendation for LYRA on May 7, 2024 04:50AM ET. LYRA was trading at $0.5215 at issue of the analyst recommendation.The overall analyst consensus :...May 7, 2024 LYRA -5.57%
UBS analyst issues NEUTRAL recommendation for CBT on May 6, 2024 08:18PM ET. The previous analyst recommendation was Neutral.CBT was trading at $95.94 at issue of the analyst...May 6, 2024 CBT 3.70%